• English
  • 简体中文
Login Register
Current Location: Home > FDA Approved Drug Products Feedback Help
-
-
Application Number Application Type Drug Name Active Ingredients Dosage Form/Route Approval Date Company
217466 ANDA OLANZAPINE OLANZAPINE INJECTABLE;INTRAMUSCULAR 2023-03-22 ASPIRO
213378 NDA LYBALVI OLANZAPINE; SAMIDORPHAN L-MALATE TABLET;ORAL 2021-05-28 ALKERMES INC
210968 ANDA OLANZAPINE OLANZAPINE INJECTABLE;INTRAMUSCULAR 2020-10-22 EUGIA PHARMA
210022 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2023-02-24 CADILA PHARMS LTD
209399 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2018-09-24 JIANGSU HANSOH PHARM
208146 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2018-07-03 HEC PHARM
206924 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2020-12-31 HISUN PHARM HANGZHOU
206892 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2020-12-31 HISUN PHARM HANGZHOU
206711 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2016-08-30 AJANTA PHARMA LTD
206238 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2018-11-19 SUNSHINE
206155 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2020-07-31 INDOCO
204866 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2017-06-16 HIKMA
204320 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2017-05-30 AJANTA PHARMA LTD
204319 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2016-01-27 QILU
203708 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2014-05-15 AUROBINDO PHARMA LTD
203456 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2016-03-16 CHARTWELL MOLECULAR
203333 ANDA OLANZAPINE OLANZAPINE TABLET;ORAL 2016-03-15 CHARTWELL MOLECULAR
203044 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2015-02-20 MACLEODS PHARMS LTD
202937 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2015-03-02 ORBION PHARMS
202889 ANDA OLANZAPINE OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 2023-03-09 ZYDUS PHARMS